In this section
@misc{Li:2023:10.1158/0008-5472.22424535.v1,
author = {Li, C and Course, MM and McNeish, IA and Drescher, CW and Valdmanis, PN and Lieber, A},
doi = {10.1158/0008-5472.22424535.v1},
title = {Supplementary Data from Prophylactic <i>In Vivo</i> Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models},
type = {Other},
url = {http://dx.doi.org/10.1158/0008-5472.22424535.v1},
year = {2023}
}
TY - GEN
AB - <jats:p><p>Supplementary Fig. S1. Rat Neu is expressed in MMC cells. Supplementary Fig. S2. Gating strategy used for immunophenotyping. Supplementary Fig. S3. Immunophenotyping of GFP+ cells in the bone marrow and spleen (MMC model). Supplementary Fig.S4. GFP expression in tumor-infiltrating leukocytes after in vivo HSPC transduction (TC-1 model). Supplementary Fig. S5. Validation of miR-423-5p expression by Northern blot. Supplementary Fig.S6. miRNA423-5p expression in humans. Supplementary Fig. S7. Autoimmune reactions in animals sacrificed at day 17 at the peak of aPDL1-gamma1, before reversal of tumor growth. Supplementary Fig. S8. Effect of anti-PDL1 monoclonal antibody therapy in neu-transgenic mice with MMC tumors. Supplementary Fig. S9. Effect of in vivo HSC transduction on hemopoiesis. Suppl. Methods</p></jats:p>
AU - Li,C
AU - Course,MM
AU - McNeish,IA
AU - Drescher,CW
AU - Valdmanis,PN
AU - Lieber,A
DO - 10.1158/0008-5472.22424535.v1
PY - 2023///
TI - Supplementary Data from Prophylactic <i>In Vivo</i> Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models
UR - http://dx.doi.org/10.1158/0008-5472.22424535.v1
UR - https://doi.org/10.1158/0008-5472.22424535.v1
ER -